Junichiro Yuda

14PUBLICATIONS
78CO-AUTHORS
Haematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 29, 2026
Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case Report.

|May 23, 2026
SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

|Dec 27, 2025
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.

Gurdeep Parmar, Marcelo Capra, Fernanda Seguro

|May 09, 2025
Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM.

Shinsuke Iida, Kazutaka Sunami, Shigeki Ito

|Oct 21, 2024
Treatment selection and influencing factors for chronic lymphocytic leukemia: a physician survey in Japan.

Junichiro Yuda, Chaochen Wang, Tomoko Terasawa

|Jul 18, 2024
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine.

Tadayoshi Hashimoto, Yoshiaki Nakamura, Takao Fujisawa

Pageof 3

Frequent Collaborators

2 joint publications

Genichiro Ishii

2 joint publications

Kazutaka Sunami

1 joint publications

Toshihiro Miyamoto

1 joint publications

SungGi Chi